1Goldberg RJ,Gore JM,Thompson CA,et al.Recent magnitude of and temporal trends (19941997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardal infarction:The second national registry of myocardial infarction.Am Heart J,2001,141 (1):65-72.
2Dixon SR,Alkafri H,Chami A.Clinical predictors of in-hospital death in patients with cardiogenic shock selected to undergo early revascularization.J Am Coll Cardiol,2002,39(suppl A):808-810.
4Hochman JS,Buller CE,Sleeper LA,et al.Cardiogenic shock complicating acute myocardial infarction:etiologies,management and outcome:overall findings of the SHOCK Trial Registry.J Am Coll Cardiol,2000,36(3):1063:1070.
5Wollert KC,Drexler H.Carvedilol prospective randomized cumulative survival (COPERNICUS)trial:carvedilol as the sun and center of the blocker world? Circulation,2002,106 (17):2164-2166.
6Feng Q,Lu X,Jones DL,et al.Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice.Circulation,2001,104 (6):700-704.
7Webb JG,Sleeper LA,Buller CE,et al.Implications of the timing of onset of cardiogenic shock after acute myocardial infarction:a report from the SHOCK Trial Registry.SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol,2000,36(3Suppl A):1084-1090.
